FINWIRES · TerminalLIVE
FINWIRES

Leerink Partners Initiates X4 Pharmaceuticals at Outperform With $12 Price Target

By

Related Articles

Research

UBS Initiates Seven Hills Realty Trust at Buy With $10 Price Target

$sevn
Research

Oppenheimer Initiates Odyssey Therapeutics at Outperform With $40 Price Target

$ODTX
Research

Cantor Fitzgerald Initiates Odyssey Therapeutics at Overweight

$ODTX